DINGDANG HEALTH TECHNOLOGY GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.03 HKD | +1.98% |
|
-3.74% | -48.24% |
| Apr. 01 | Dingdang Health Technology Slashes Losses in 2023 | MT |
| Mar. 28 | Dingdang Health Technology Group Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Dingdang Health Technology Group Ltd is a China based company mainly engaged in the business of pharmaceutical retail and medical consultation. The Company operates two segments. Pharmaceutical and Healthcare Business segment is engaged in online direct sales, business distribution, offline smart pharmacies, express delivery services, and online medical consultation. Others segment provides marketing services, marketplace services and other services. The Company mainly conducts businesses within the domestic market.
Sector
Drug Retailers
Calendar
2024-09-19
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9522
CNY
Average target price
1.366
CNY
Spread / Average Target
+43.46%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -48.24% | 173M | |
| -30.41% | 15.72B | |
| -38.36% | 9.56B | |
| -10.39% | 6.13B | |
| +8.92% | 6.02B | |
| -36.56% | 5.46B | |
| 0.00% | 4.85B | |
| +48.75% | 4.24B | |
| -11.71% | 3.61B | |
| -19.68% | 3.46B |
- Stock Market
- Equities
- 9886 Stock
- News Dingdang Health Technology Group Ltd.
- Dingdang Health Technology's H1 Loss Narrows on Higher Revenue
